Global thickness for accurate and precise evaluation of post-intervention remodelling in left ventricular hypertrophy
- 1University of Sydney
Abstract
Background: Cardiovascular interventions may impact both left ventricular mass (LVM) and end-diastolic volume (EDV), but the net effect on wall thickness has been difficult to accurately evaluate. Global average left ventricular end-diastolic wall thickness (GT) relates non-linearly to LVM and EDV. We hypothesized that if GT is independent of EDV in health, then GT will be an ideal measure of post-intervention change in left ventricular hypertrophy. Methods: GT [mm] was calculated using LVM and EDV by cardiovascular magnetic resonance as previously validated. The correlation between GT and EDV was evaluated in healthy volunteers. Change in GT following intervention was evaluated for aortic stenosis undergoing valve replacement, hypertension commencing antihypertensive medications, athletes undergoing forced detraining, and aortic regurgitation undergoing valve replacement. The performance of GT was compared to LVM/EDV. Results: Among healthy volunteers (n=4461, mean+/-SD age 59+/-10 years, 50% female), EDV correlated with LVM/EDV but negligibly with GT (R2>0.16 vs R2<0.02, p<0.001 for both sexes). GT and not LVM/EDV changed after intervention in all conditions (p[≤]0.02 for all). Post-intervention changes in GT varied by condition (mean+/-SEM aortic stenosis [n=102]: -1.75+/-0.13mm, hypertension [n=78]: -0.66+/-0.08mm, athletes [n=28]: -0.29+/-0.09mm, aortic regurgitation [n=58]: +0.50+/-0.11 mm, p[≤]0.02 for all comparisons). Conclusions: In health, GT, unlike LVM/EDV, remains effectively unchanged across EDV values, indicating that GT is a physiological constant in health and can track pathological changes. After intervention, only GT and not LVM/EDV consistently changed. Instead of LVM/EDV, GT should be used to quantify remodelling after interventions in left ventricular hypertrophy.
Related
- Curriculum-Based Deep Learning for Automated Segmental Left Ventricular Hypertrophy Classification Using Short-Axis Echocardiography
- Echocardiographic Left Ventricular Hypertrophy Among Patients with Type 2 Diabetes Undergoing Clinically Indicated Echocardiography at a Saudi Cardiac Center: Prevalence and Associated Factors
- Left ventricular hypertrophy, brain atrophy and cognitive decline in type 2 diabetes mellitus: Diabetes & Dementia (D2) cohort study
- Delayed left ventricular remodelling in patients with heart failure and reduced ejection fraction: a systematic review.
- Atorvastatin Prevents Early Lipotoxic Remodelling in Right Ventricular Pacing–Induced Cardiomyopathy
BibTeX
@misc{khor2026global,
title = {{Global thickness for accurate and precise evaluation of post-intervention remodelling in left ventricular hypertrophy}},
author = {L. Khor and H. Shiwani and G. D. Thornton and J. Bennett and N. Aziminia and A. Shetye and C.-C. Topriceanu and G. Captur and R. H. Davies and J. C. Moon and P. Swoboda and C. W. Chin and T. A. Treibel and R. Kozor and M. Ugander},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.01.26367004},
url = {https://www.medrxiv.org/content/10.64898/2026.11.01.26367004v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Global thickness for accurate and precise evaluation of post-intervention remodelling in left ventricular hypertrophy
AU - L. Khor
AU - H. Shiwani
AU - G. D. Thornton
AU - J. Bennett
AU - N. Aziminia
AU - A. Shetye
AU - C.-C. Topriceanu
AU - G. Captur
AU - R. H. Davies
AU - J. C. Moon
AU - P. Swoboda
AU - C. W. Chin
AU - T. A. Treibel
AU - R. Kozor
AU - M. Ugander
PY - 2026
DA - 2026/11/01
PB - medRxiv
DO - 10.64898/2026.11.01.26367004
UR - https://www.medrxiv.org/content/10.64898/2026.11.01.26367004v1
AB - Background: Cardiovascular interventions may impact both left ventricular mass (LVM) and end-diastolic volume (EDV), but the net effect on wall thickness has been difficult to accurately evaluate. Global average left ventricular end-diastolic wall thickness (GT) relates non-linearly to LVM and EDV. We hypothesized that if GT is independent of EDV in health, then GT will be an ideal measure of post-intervention change in left ventricular hypertrophy. Methods: GT [mm] was calculated using LVM and EDV by cardiovascular magnetic resonance as previously validated. The correlation between GT and EDV was evaluated in healthy volunteers. Change in GT following intervention was evaluated for aortic stenosis undergoing valve replacement, hypertension commencing antihypertensive medications, athletes undergoing forced detraining, and aortic regurgitation undergoing valve replacement. The performance of GT was compared to LVM/EDV. Results: Among healthy volunteers (n=4461, mean+/-SD age 59+/-10 years, 50% female), EDV correlated with LVM/EDV but negligibly with GT (R2>0.16 vs R2<0.02, p<0.001 for both sexes). GT and not LVM/EDV changed after intervention in all conditions (p[≤]0.02 for all). Post-intervention changes in GT varied by condition (mean+/-SEM aortic stenosis [n=102]: -1.75+/-0.13mm, hypertension [n=78]: -0.66+/-0.08mm, athletes [n=28]: -0.29+/-0.09mm, aortic regurgitation [n=58]: +0.50+/-0.11 mm, p[≤]0.02 for all comparisons). Conclusions: In health, GT, unlike LVM/EDV, remains effectively unchanged across EDV values, indicating that GT is a physiological constant in health and can track pathological changes. After intervention, only GT and not LVM/EDV consistently changed. Instead of LVM/EDV, GT should be used to quantify remodelling after interventions in left ventricular hypertrophy.
ER -